Drug intelligence / Profile preview

Hyper-NC

Development stage
Unknown
Lead developer
Grevis Pharma
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Hyper-NC is a topical ophthalmic solution containing hypertonic sodium chloride, developed and marketed by Grevis Pharma. It is primarily indicated for the temporary relief of corneal edema and the reduction of epithelial swelling. The drug operates through a physical osmotic mechanism rather than binding to a specific molecular receptor. By increasing the tonicity of the tear film, it creates an osmotic gradient that draws excess fluid out of the edematous corneal epithelium and stroma. This reduction in swelling helps improve visual clarity and alleviate discomfort associated with conditions such as Fuchs' endothelial dystrophy or post-surgical corneal edema.

Brand names
Hyper-NC
Other names
Sodium chloride (hypertonic) ophthalmic solutionHypertonic saline eye drops

Beyond the preview

Go deeper on Hyper-NC.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hyper-NC.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call